Clinical Trial Update: Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy [Phase 1]

View source ↗

Summary

An early-phase Phase 1 study evaluating the use of the Xoft Axxent electronic brachytherapy system for intraoperative balloon brachytherapy in newly diagnosed g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Xoft Axxent Electronic Brachytherapy System

Snippet

Sponsor: Joint Stock Company European Medical Centre | Conditions: Glioblastoma | Phase 1 | Status: RECRUITING